This topic contains a solution. Click here to go to the answer

Author Question: What is the approximate range of masses that newborn main-sequence stars can have? A) 0.001 to ... (Read 104 times)

maegan_martin

  • Hero Member
  • *****
  • Posts: 532
What is the approximate range of masses that newborn main-sequence stars can have?
 
  A) 0.001 to 150 solar masses
  B) 0.1 to 1,000 solar masses
  C) 0.1 to 150 solar masses
  D) 0.001 to 10 solar masses
  E) 0.1 to 10 solar masses

Question 2

The age of our solar system is approximately
 
  A) 10,000 years.
  B) 3.8 million years.
  C) 4.6 million years.
  D) 4.6 billion years.
  E) 14 billion years.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

reversalruiz

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

C

Answer to Question 2

D




maegan_martin

  • Member
  • Posts: 532
Reply 2 on: Jul 27, 2018
Great answer, keep it coming :)


billybob123

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library